Patisiran Wins Two Firsts With FDA Approval
(MedPage Today) -- RNAi drug OK ' d to treat polyneuropathy from hereditary transthyretin amyloidosis
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Amyloidosis | Primary Care